Biosimilars and products designed to help you deliver trusted and affordable medicines at speed.
Our portfolio consists of a diverse range of products and technologies — including EnzeneX™, our revolutionary continuous manufacturing technology that streamlines production — to cater to the needs of the biopharmaceutical industry.
We are committed to continuous innovation and developing cutting-edge solutions that address real-world challenges.
A biosimilar partner from any stage, a strong product pipeline and other solutions to meet your needs.
We are driven by the vision of positively impacting the global healthcare landscape by bringing trusted and affordable medicines to market at speed, by offering services that encompass licensing, co-development or working as a CDMO.
Committed to innovation, we have revolutionized the field of continuous manufacturing through our proprietary EnzeneX™ technology, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars are designed to cater to your project’s every need.
With years of technical expertise and a platform that pushes your projects further, your progress is our priority.
EnzeneX™ is an advanced bioprocess manufacturing platform that harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics.
Designed for efficiency and cost-effectiveness, EnzeneX™ enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
Reach out today to discover how our AAV technology and biosimilars pipeline can help you deliver trusted and affordable medicines at speed.